Loading…
CIK 0001910456 • 7 13F filings • May 15, 2025 – Aug 13, 2026
Import this data to Google Sheets with:
=jivedata("lynx1-capital-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ALLOGENE THERAPEUTICS INC | COM | $16.1M | 5.8% | 11,057,009 SH | |
| C4 THERAPEUTICS INC | COM STK | $11.4M | 4.1% | 7,098,133 SH | |
| CULLINAN THERAPEUTICS INC | COM | $24.3M | 8.7% | 3,215,722 SH | |
| DESIGN THERAPEUTICS INC | COM | $255K | 0.1% | 65,954 SH | |
| GH RESEARCH PLC | ORDINARY SHARES | $71.1M | 25.5% | 6,443,940 SH | |
| IBIO INC | CON NEW | $3.5M | 1.2% | 862,279 SH | |
| MERUS N V | COM | $66.0M | 23.6% | 1,568,841 SH | |
| NEUPHORIA THERAPEUTICS INC | COM | $264K | 0.1% | 45,806 SH | |
| PASSAGE BIO INC | COM | $3.3M | 1.2% | 9,256,953 SH | |
| PRECISION BIOSCIENCES INC | COM NEW | $3.7M | 1.3% | 766,051 SH | |
| PROTAGONIST THERAPEUTICS INC | COM | $35.4M | 12.7% | 733,014 SH | |
| STOKE THERAPEUTICS INC | COM | $35.2M | 12.6% | 5,291,929 SH | |
| TSCAN THERAPEUTICS INC | COM | $7.4M | 2.6% | 5,357,347 SH | |
| UPSTREAM BIO INC | COM | $1.3M | 0.5% | 219,247 SH |
| 13F-HR/A |
| 0001910456-26-000004 |
| $865.5M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001085146-25-005127 | $346.2M | View |
| May 4, 2026 | Q1 2026 | 13F-HR | 0001910456-26-000002 | $632.7M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001892688-25-000120 | $279.2M | View |